US Biosimilars ‘Bumpy’ For Teva As It Prepares For Alvotech Inspection

CEO Hints At More Deals On The Horizon Despite A Degree Of Market Uncertainty

 
• By David Wallace
  
Road sign warning of bumps ahead
Teva’s CEO sees the US market as “bumpy” • Source: Shutterstock

More from Strategy

More from Business